ContractLetter Agreement • March 29th, 2024 • Accelerate Diagnostics, Inc • Laboratory analytical instruments
Contract Type FiledMarch 29th, 2024 Company Industry
March 9, 2023 David Patience Delivered Electronically via EmailLetter Agreement • May 15th, 2023 • Accelerate Diagnostics, Inc • Laboratory analytical instruments
Contract Type FiledMay 15th, 2023 Company IndustryCongratulations! We are delighted to enter into this Letter Agreement (the “Agreement”) to memorialize the terms under which you will serve first as an employee of Accelerate Diagnostics, Inc. (the “Company”) as Chief Financial Officer of the Company.
January 31, 2020Letter Agreement • February 28th, 2020 • Accelerate Diagnostics, Inc • Laboratory analytical instruments
Contract Type FiledFebruary 28th, 2020 Company IndustryWe are delighted to enter into this Letter Agreement (the “Agreement”) under which you will serve as the Chief Executive Officer of Accelerate Diagnostics, Inc. (the “Company”). Your start date as President and Chief Executive Officer will be February 1, 2020 (“Start Date”). Once this Agreement becomes effective, it will form the entire agreement between you and the Company with respect to the matters described in this Agreement and it will supersede and replace any prior understandings (whether oral or written) with respect to the subject matter described herein, including the letter agreement between you and the Company, dated August 6, 2019.